New first-line therapy for dMMR/MSI-H CRC
- PMID: 33349691
- DOI: 10.1038/s41571-020-00464-y
New first-line therapy for dMMR/MSI-H CRC
Comment on
-
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Clinical Trial.
References
Original article
-
- André, T. et al. Pembrolizumab in microsatellite-instability–high advanced colorectal cancer. N. Engl. J. Med. 383, 2207–2218 (2020) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical